The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $49.58

Today's change0.00 0.00%
Updated June 2 4:04 PM EDT. Delayed by at least 15 minutes.
 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $49.58

Today's change0.00 0.00%
Updated June 2 4:04 PM EDT. Delayed by at least 15 minutes.

Zoetis Inc closed at (U.S.)$49.58.

Over the last five days, shares have gained 3.40% and are currently 1.56% off of the 52-week high. Shares have outperformed the S&P 500 by 50.76% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $49.58
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+15.22%
  • Volume0
  • Average volume (10-day)3,868,127
  • Average volume (1-month)3,619,865
  • Average volume (3-month)3,210,100
  • 52-week range(U.S.) $30.65 to (U.S.) $50.37
  • Beta--
  • Trailing P/E42.03×
  • P/E 1 year forward30.05×
  • Forward PEG2.76×
  • Indicated annual dividend(U.S.) $0.33
  • Dividend yield0.67%
  • Trailing EPS(U.S.) $1.18
Updated June 2 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.46%

Based on its net profit margin of 12.46%, Zoetis Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 29, 201503/29/2015Dec 31, 201412/31/2014Sep 28, 201409/28/2014Jun 29, 201406/29/2014
Revenue1,1021,3201,2101,158
Total other revenue--------
Total revenue1,1021,3201,2101,158
Gross profit708829776745
Total cost of revenue394491434413
Total operating expense8721,165972958
Selling / general / administrative354497394396
Research & development801249392
Depreciation / amortization15141615
Interest expense (income), net operating28302929
Unusual expense (income)113712
Other operating expenses, total-8-9-8-6
Operating income230155238200
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax230155238200
Income after tax165126167139
Income tax, total65297161
Net income165126166136
Total adjustments to net income--------
Net income before extra. items165126166136
Minority interest00-1-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items165126166136
Inc. avail. to common incl. extra. items165126166136
Diluted net income165126166136
Dilution adjustment0------
Diluted weighted average shares503503502502
Diluted EPS excluding extraordinary itemsvalue per share0.330.250.330.27
Dividends per sharevalue per share0.080.160.070.00
Diluted normalized EPSvalue per share0.330.270.340.29